516 related articles for article (PubMed ID: 18774558)
1. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
Orvieto R; Meltcer S; Homburg R; Nahum R; Rabinson J; Ashkenazi J
Fertil Steril; 2009 Apr; 91(4 Suppl):1466-8. PubMed ID: 18774558
[TBL] [Abstract][Full Text] [Related]
2. GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori.
Orvieto R; Homburg R; Meltcer S; Rabinson J; Anteby EY; Scharf S
Fertil Steril; 2009 Apr; 91(4 Suppl):1378-80. PubMed ID: 18675972
[TBL] [Abstract][Full Text] [Related]
3. Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality.
Orvieto R; Nahum R; Rabinson J; Gemer O; Anteby EY; Meltcer S
Fertil Steril; 2009 Apr; 91(4 Suppl):1398-400. PubMed ID: 18675974
[TBL] [Abstract][Full Text] [Related]
4. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
5. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study.
Bahçeci M; Ulug U; Ben-Shlomo I; Erden HF; Akman MA
J Reprod Med; 2005 Feb; 50(2):84-90. PubMed ID: 15755044
[TBL] [Abstract][Full Text] [Related]
6. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
7. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
8. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
[TBL] [Abstract][Full Text] [Related]
9. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
[TBL] [Abstract][Full Text] [Related]
10. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT).
Lainas TG; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas GT; Alexopoulou E; Kolibianakis EM
Hum Reprod; 2010 Mar; 25(3):683-9. PubMed ID: 20008886
[TBL] [Abstract][Full Text] [Related]
11. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
12. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
[TBL] [Abstract][Full Text] [Related]
13. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
14. Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome.
Fusi FM; Arnoldi M; Bosisio C; Lombardo G; Ferrario M; Zanga L; Galimberti A; Capitanio E
Gynecol Endocrinol; 2015; 31(9):693-7. PubMed ID: 26527503
[TBL] [Abstract][Full Text] [Related]
15. GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.
Giles J; Requena A; García-Velasco JA; Pacheco A; Pellicer J; Pellicer A
Fertil Steril; 2009 Apr; 91(4 Suppl):1366-9. PubMed ID: 18692821
[TBL] [Abstract][Full Text] [Related]
16. Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?
Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
Gynecol Endocrinol; 2012 Jun; 28(6):422-4. PubMed ID: 22578028
[TBL] [Abstract][Full Text] [Related]
17. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
[TBL] [Abstract][Full Text] [Related]
18. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
Das M; Son WY; Buckett W; Tulandi T; Holzer H
Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
[TBL] [Abstract][Full Text] [Related]
19. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
20. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.
Orvieto R; Nahum R; Meltzer S; Liberty G; Anteby EY; Zohav E
Gynecol Endocrinol; 2013 Sep; 29(9):843-5. PubMed ID: 23802563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
